Director/PDMR Shareholding

RNS Number : 3068V

Epistem Holdings plc

10 January 2013

 



Epistem Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 198 ordinary shares of 1.5p each. These shares were acquired on 18 October 2012, 22 November 2012 and 13 December 2012 at prices of 556p, 575p and 575p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                             9,979                                   0.10%

Dr Catherine Booth                  984,334                                 10.19%

Dr Jeffrey Moore                       13,659                                   0.14%

John Rylands                            194,232                                   2.01%

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                    [phone]

John Rylands, Finance Director                                      [phone]

Peel Hunt LLP

James Steel /Vijay Barathan                                           [phone]

 

END

 

 

RDSBLGDBDXBBGXG